Details of the presentation are as follows:
Title: Efficacy and Safety of a Third Generation CD20 CAR-T (MB-106) for Treatment of Relapsed/Refractory Indolent B-Cell Non-Hodgkin Lymphoma: Phase-1 Results from a Multicenter Trial
Session Name: 704. Cellular Immunotherapies: Early Phase and Investigational Therapies: Poster I
Date and Time: Saturday, December 9, 2023, 5:30 pm - 7:30 pm PT
Location: San Diego Convention Center, Halls G-H
Abstract Number: 2102
Presenter: Mazyar Shadman, M.D., M.P.H., Study Chair, Innovators Network Endowed Chair at Fred Hutch, Associate Professor and physician at Fred Hutch and University of Washington
For more information, please visit the 65th ASH Annual Meeting and Exposition website at https://www.hematology.org/meetings/annual-meeting/abstracts.